Isodeoxyelephantopin mitigates DSS-induced ulcerative colitis by suppressing IL-1β-driven inflammation via the TXNIP/NLRP3 axis
- 16 January 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 153, 157839
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 22 references indexed in Scilit:
- Development of Novel Piperine‐Loaded Mesoporous Silica Nanoparticles: Enhanced Drug Delivery and Comprehensive In Vivo Safety AnalysisChemistry & Biodiversity, 2025
- Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative ColitisCellular and Molecular Gastroenterology and Hepatology, 2022
- Isodeoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber Linn., inhibits pro-inflammatory mediators’ production through both NF-κB and AP-1 pathways in LPS-activated macrophagesInternational Immunopharmacology, 2020
- Green tea polyphenols prevent lipopolysaccharide-induced inflammatory liver injury in mice by inhibiting NLRP3 inflammasome activationFood & Function, 2019
- Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β productionMolecular Immunology, 2018
- Ulcerative colitisThe Lancet, 2017
- The global burden of IBD: from 2015 to 2025Nature Reviews Gastroenterology & Hepatology, 2015
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagyJournal of Cellular Physiology, 2014
- Thioredoxin-interacting protein links oxidative stress to inflammasome activationNature Immunology, 2009
- Infliximab for induction and maintenance therapy for ulcerative colitisGastroenterology, 2006